I’ll finish on the theme of opportunity. Australia and New Zealand have very strong scientific track records for MRI research in institutions such as the Centre for Advanced Imaging and the Herston Imaging Research Facility in Brisbane, the University of Sydney, the Florey Institute in Melbourne, and the Centre for Advanced MRI in Auckland, to name but a few. Many important developments have and are occurring here: high field (7T) MRI, PET-MR, Constrained Spherical Deconvolution tractography with track density imaging, and the MR-Linac. Where are the DIMPs and the ROMPs in these developments? We should be translating these technologies into clinical practice. This is our big opportunity, but it will become a weakness if we remain on the periphery of these exciting advances.
We need to develop our members’ expertise in MR safety. Here the paradigm has changed fundamentally: from “what you must not scan” to “what you can scan and under what conditions” with regard to both passive and active implants. The three professionals model of MR safety is rapidly gaining worldwide acceptance: the MR Medical Director, the MR Safety Officer, and the MR Safety Expert. The Institute of Physics and Engineering in Medicine has published guidance on the knowledge and skills of the MR Safety Expert (MRSE) [17] as a professional (usually a medical engineer or physicist) capable of determining the potential risks from implants and exposures from first principles. A MRSE fully understands the underlying physics, the technology, the nature of the tissue (and device) interactions, the clinical applications, and can quantify the risk—just like we do in radiation physics. We should be stepping into this role. In the USA, the independently-constituted American Board of MR Safety has also adopted the three professionals model.
I have been asked by some younger colleagues, how do we get involved with MRI? It’s a slow process of gaining confidence, becoming fluently conversant with clinical MRI (i.e. knowing and understanding the pulse sequences which are relevant to clinical users), and winning respect and trust. Helping with quantitative metrics is a good starting point, as is translational research or service development. At Flinders, our clinical head was very keen to implement the Constrained Spherical Deconvolution method of tractography, pioneered in Melbourne [18,19,20]. This had not been done before in a public hospital setting, and presents many issues of optimising the MR acquisition, the post processing, ensuring quality and the deployment of other clinical science skills that are second nature to medical physicists. Initial results have been promising [21, 22] and the experience rates as one of the most satisfying so far in my career, and has genuinely changed patients’ lives. One of my long term goals is to see the development of MR physics expertise and education within the public health sector.
I’m grateful to the Editors for the opportunity to write this piece, and to all my colleagues for their support and inspiration.